Your browser doesn't support javascript.
loading
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer.
Sinha, Meenal; Zhang, Li; Subudhi, Sumit; Chen, Brandon; Marquez, Jaqueline; Liu, Eric V; Allaire, Kate; Cheung, Alexander; Ng, Sharon; Nguyen, Christopher; Friedlander, Terence W; Aggarwal, Rahul; Spitzer, Matthew; Allison, James P; Small, Eric J; Sharma, Padmanee; Fong, Lawrence.
Afiliación
  • Sinha M; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Zhang L; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Subudhi S; Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Chen B; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Division of Cancer Medicine, Houston, Texas, USA.
  • Marquez J; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Liu EV; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Allaire K; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Cheung A; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Ng S; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Nguyen C; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Friedlander TW; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Aggarwal R; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Spitzer M; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Allison JP; Department Hematology/Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Sharma P; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA.
  • Fong L; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
J Immunother Cancer ; 9(5)2021 05.
Article en En | MEDLINE | ID: mdl-33986125
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Extractos de Tejidos / Biomarcadores de Tumor / Linfocitos Infiltrantes de Tumor / Células TH1 / Vacunas contra el Cáncer / Microambiente Tumoral / Neoplasias de la Próstata Resistentes a la Castración / Ipilimumab / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Extractos de Tejidos / Biomarcadores de Tumor / Linfocitos Infiltrantes de Tumor / Células TH1 / Vacunas contra el Cáncer / Microambiente Tumoral / Neoplasias de la Próstata Resistentes a la Castración / Ipilimumab / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos